Table of Contents
1 Industry Outlook
1.1 Industry Overview
1.1.1 Global Driver for Pharmaceutical Demand
1.1.2 Pharmaceutical Spending Region Wise
1.1.3 R&D Pipeline in Pharmaceutical Industry
1.1.4 Top Pharma Drugs by Sales in 2017 ($Million)
1.2 Total Addressable Market
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Market Definition - Infoholic Research 3.2 Segmented Addressable Market (SAM)
3.3 Industry Trends
3.4 Related Markets
3.4.1 Parkinson's Disease
4 Market Outlook
4.1 Market Segmentation
4.2 Porter 5 (Five) Forces
5 Market Characteristics
5.1 Market Dynamics
5.1.1 Drivers
5.1.1.1 Promising pipeline in development
5.1.1.2 Increase in geriatric population
5.1.2 Restraints
5.1.2.1 Failures of late-stage drugs
5.1.2.2 Restricted awareness about Alzheimer's disease
5.1.3 Opportunities
5.1.3.1 Emerging novel diagnostic technologies
5.1.3.2 Investment in biomarkers for drug development
5.1.4 DRO - Impact Analysis
5.2 Key Stakeholders
6 Molecule Type: Market Size and Analysis
6.1 Overview
6.2 Cholinesterase Inhibitors
6.3 NMDA Receptor Antagonists
6.4 Others
7 Distribution Channel: Market Size and Analysis
7.1 Overview
7.2 Hospital Pharmacies
7.3 Retail Pharmacies
7.4 E Pharmacies
8 Regions: Market Size and Analysis
8.1 Overview
8.2 North America
8.3 Europe
8.4 Asia Pacific
8.5 Rest of the World
9 Competitive Landscape
10 Vendors Profile
10.1 Novartis AG
10.2 Eisai Co. Ltd.
10.3 Pfizer Inc.
10.4 Eli Lilly & Company
10.5 Johnson & Johnson
11 Companies to Watch for
11.1 Daiichi Sankyo Company Ltd
11.2 F. Hoffmann-La Roche
11.3 H. Lundbeck A/S
11.4 TauRx Therapeutics Ltd
11.5 Allergan
Annexure
Abbreviations
